Binfeng Lu

9PUBLICATIONS

36CO-AUTHORS

Molecular targetsCancer geneticsTumour immunologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|Jul 06, 2026

mTORC1 suppression by Trp53 mutation drives resistance to immune checkpoint blockade.

|Apr 17, 2026

Dedifferentiation-driven oncogenic stemness promotes tumor-sustaining adaptability in the intestinal epithelium.

|Jul 24, 2025

Specific inhibitor to KRAS<sup>G12C</sup> induces tumor-specific immunity and synergizes with oncolytic virus for enhanced cancer immunotherapy.

Zhi Zhu, Hongqi Chen, Chao Feng

|Feb 16, 2024

Measuring the composition of the tumor microenvironment with transcriptome analysis: past, present and future.

Han Zhang, Xinghua Lu, Binfeng Lu

|Jan 04, 2024

Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy.

Zhangyi Luo, Yixian Huang, Neelu Batra

|Aug 23, 2023

Amphiregulin couples IL1RL1<sup>+</sup> regulatory T cells and cancer-associated fibroblasts to impede antitumor immunity.

Runzi Sun, Hongyu Zhao, David Shihong Gao

Pageof 2

Frequent Collaborators

Song Li

Da Yang

Yuang Chen

Min Zhang

Ziqian Zhang

James F Conway

Xinghua Lu

Zhuoya Wan

Guolian Ren

Xiaochao Ma

Frequent Collaborators

Song Li

Da Yang

Yuang Chen

Min Zhang